CDKL3 promotes osteosarcoma progression by activating Akt/PKB
Sign Up to like & getrecommendations! Published in 2020 at "Life Science Alliance"
DOI: 10.26508/lsa.202000648
Abstract: This study demonstrates that CDKL3 regulates Akt activation and its downstream targets to promote OS progression, creating a therapeutically targetable vulnerability in treatment of OS. Osteosarcoma (OS) is a primary malignant bone neoplasm with high… read more here.
Keywords: akt activation; akt pkb; progression; cdkl3 ... See more keywords